Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve

Charles C. Vining, Francisco Izquierdo, Oliver S. Eng, Kiran K. Turaga

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved safety and favorable oncologic outcomes, including curative potential. CRS/HIPEC has a steep learning curve and requires familiarity with peritonectomy procedures. This review will outline the technical aspects and learning curve of CRS/HIPEC.

Original languageEnglish (US)
Pages (from-to)85-95
Number of pages11
JournalJournal of Surgical Oncology
Volume122
Issue number1
DOIs
StatePublished - Jul 1 2020

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this